SCHEDULE: Bank of America Discloses 5.2% Stake in Outset Medical
Beneficial Ownership Report
Bank of America Corporation has reported a 5.2% beneficial ownership stake in Outset Medical, Inc., holding 950,558 shares of common stock.
Summary
- Bank of America Corporation /DE/ has filed a Schedule 13G, indicating beneficial ownership in Outset Medical, Inc.
- The filing reports an aggregate beneficial ownership of 950,558 shares of Outset Medical, Inc. Common Stock.
- This ownership represents 5.2% of the class of securities, based on 18,153,090 outstanding shares as disclosed in the issuer's Form 10-Q on November 10, 2025.
- Bank of America holds shared voting power over 950,501 shares and shared dispositive power over 950,549 shares.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it simply discloses a significant institutional ownership stake without providing new operational or financial data. The presence of a major bank as a beneficial owner can be seen as a minor positive signal.
Positives
- A major financial institution, Bank of America, holds a significant stake, potentially indicating confidence in Outset Medical, Inc.
Negatives
- No specific negative information is disclosed in this beneficial ownership report.
Risks
- No specific risks related to Outset Medical, Inc. are detailed in this beneficial ownership report.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that institutional filings like this Schedule 13G provide transparency into significant ownership positions, which can sometimes signal institutional confidence or strategic interest in a company within the medical device sector. While this filing doesn't offer operational insights, it confirms a major financial player's stake in Outset Medical.
Stakeholder Impact
- Shareholders: Increased transparency regarding a significant institutional holder, potentially signaling stability or institutional interest.
Key Dates
| Date | Description |
|---|---|
| 2025-11-06 | Date as of which outstanding shares were reported in Outset Medical's Form 10-Q. |
| 2025-11-10 | Date Outset Medical filed its Form 10-Q disclosing 18,153,090 outstanding shares. |
| 2025-12-31 | Date of the event which required the filing of this statement. |
| 2026-02-11 | Date the Schedule 13G was signed by Bank of America Corp /DE/. |
Keywords
Outset Medical, Bank of America, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Ownership, Medical Devices
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.